Harvard Business

JUNE 4, 2018

” “Our goal,” it stated, “must be to develop the talents of all to their fullest.” The talents of all are not being developed to their fullest, and many U.S. million job openings , which companies are struggling to find the right talent to fill. industries face acute skills shortages.

Education 71

Education Talent Company Accenture 71

Harvard Business

JULY 11, 2018

To focus on businesses that are closer in spirit to the prototypical high-tech startup, we used a variety of indicators: whether the firm was granted a patent, received VC investment, or operated in an industry that employs a high fraction of STEM workers. These prominent founders may not have peaked when very young.

Research 134

Research Biotechnology Industry Media 134

Harvard Business

SEPTEMBER 21, 2018

Innovation ranks fifth, after more-conventional concerns such as attracting and retaining top talent and the regulatory environment. This isn’t all that surprising given the level of innovation activity in these sectors, but directors operating in similarly disrupted sectors should take note.

Telecommunications 126

Telecommunications Survey Biotechnology Industry 126

Management Consulted

MAY 7, 2017

McKinsey’s Bay Area operation consists of two offices: San Francisco and Silicon Valley. However, e mployees at these two offices rave about the energy in the workplace, and Accenture has done a good job of building a culture of mentorship in its Bay Area operation. Deloitte Consulting , 101 Market St.,

Consulting 113

Consulting Bain Deloitte McKinsey 113

Harvard Business

AUGUST 23, 2016

Boards of companies operating in the consumer discretionary industry have a disproportionately high representation of Democrats, while boards operating in the industrials and energy and utilities industries skew more Republican. pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Telecommunications 70

Telecommunications Biotechnology Survey Healthcare 70

Tom Spencer

JANUARY 17, 2025

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. Initiatives like Operation Warp Speed demonstrated that public-private partnerships can accelerate innovation.

Policies 88

Policies Healthcare Biotechnology Industry 88